{"url_path":"/sec/imdx/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-022721-index.html","accession_number":"0001493152-26-022721","cik":"0001642380","ticker":"IMDX","issuer_name":"Insight Molecular Diagnostics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1642380/0001493152-26-022721-index.html","primary_entity_key":"0001642380","primary_entity_name":"Insight Molecular Diagnostics Inc."},"word_count":81,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n** **\n\n**(d)\nExhibits**\n\n \n\n**Exhibit Number**\n** **\n**Description**\n\n99.1\n \n[Press Release dated May 13, 2026](ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the\nInline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**INSIGHT MOLECULAR DIAGNOSTICS INC.**\n\n \n \n \n\nDate: May 13, 2026\nBy:\n*/s/ Peter Hong*\n\n \nName:\nPeter Hong\n\n \nTitle:\nVice President, General Counsel"}